Prospero Biosciences has developed an ion detector that effectively increases the characterization and identification capabilities that is 30 times better than what is currently available. With our patented detection system, our researchers can extend the dynamic range limits with unmatched resolution and sensitivity in the field of mass spectrometry. Our detection system will assist scientists and clinicians make advancements for applications in virus detection, proteomics, pharmaceuticals, and diagnostics.
We provide a high mass molecule detector for the mass spectrometry market, more specifically for the MALDI-TOF and Q-TOF segment. The technology provides 15 times better resolution compared to the competitor, which is crucial for accurate identification. The company is currently developing a universal detector.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2012
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Prospero BioSciences founded?
Prospero BioSciences was founded in 2012.
What industry is Prospero BioSciences in?
Prospero BioSciences operates in Nanotechnology Research. Find similar Nanotechnology Research investors on gritt.io.
Find investors for your startup like Prospero BioSciences
Gritt sends AI-personalised outreach to each investor — from your Gmail
